<DOC>
	<DOC>NCT02550899</DOC>
	<brief_summary>A randomized study to evaluate the safety and effects of transanal submucosal polyacrylamide hydrogel injection therapy for anal incontinence.</brief_summary>
	<brief_title>Polyacrylamide Hydrogel Injection Treatment for Anal Incontinence</brief_title>
	<detailed_description>A prospective randomized study to assess the use of Bulkamid for anal incontinence using three different transanal injection techniques . Patients with anal incontinence severity Wexner score &gt;7. Standardised injection treatment at baseline. Clinical status and subjective symptom evaluation (Wexner score and FIQL) at baseline, 2 months, 6 months and 1 year.</detailed_description>
	<mesh_term>Fecal Incontinence</mesh_term>
	<criteria>informed consent, anal incontinence with Wexner score &gt;10 ino additional pregnancies, schedule for pelvic organ surgery within 1 year of treatment, current or previous pelvic organ cancer, insulin treated diabetes, inflammatory bowel disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>